Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3433-3440
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3433
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3433
Genes | Location relative to transcription start site | Genes | Location relative to transcription start site |
ABCC4 | -487 to +466 | GSTP1 | -391 to +91 |
ABCC1 | -356 to +406 | hMLH1 | -72 to +393 |
ABCC13 | +138 to +386 | KIAA1337 | -553 to +413 |
ABCC3 | -96 to +358 | MAPK14 | -371 to +319 |
ABCB11 | +1 255 to +1 565 | OCLN | -9 to +967 |
ABCC5 | -219 to +87 | POLB | -209 to +34 |
ABCC6 | -229 to +89 | RAF1 | -466 to +399 |
ABCC8 | -185 to +531 | RALBP1 | -901 to +325 |
ABCG2 | -741 to -17 | RRM2 | -718 to +426 |
ATF2 | -418 to +545 | SKP2 | -663 to +182 |
B2M | -170 to +83 | SLC19A1 | -719 to +268 |
BCAR3 | -328 to +126 | SLC22A1L | -265 to +158 |
BCL2 | -7 to +573 | SPF45 | -547 to +92 |
BIRC4 | -527 to -235 | SRI | -251 to +257 |
CAT | +35 to +395 | SSA2 | -195 to +152 |
CFTR | -515 to -55 | TOP2A | -123 to +506 |
DCK | -267 to +155 | TOP2B | -805 to +393 |
ERBB2 | +173 to +534 | TP53 | +130 to +337 |
Resistance mechanism | Genes and ref. | Function |
Plasma membrane | ABCG2 | Belongs to the abc transporter family, appears to play a major role in the multidrug resistance |
transporters/pump | phenotype of MCF-7 breast cancer cell line. When over-expressed, the transfected cells become | |
decrease or increase to | resistant to mitoxantrone, daunorubicin and doxorubicin, display diminished intracellular | |
concentration | accumulation reduce intracellular drug of daunorubicin, and manifest an | |
ATP-dependent increase in the efflux of rhodamine | ||
CFTR | Belongs to the abc transporter family. MRP subfamily, involved in the transport of chloride ions | |
RALBP1 | Activates specifically hydrolysis of GTP bound to RAC1 and CDC42. Mediates ATP-dependent | |
transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin(DOX) and is the major | ||
ATP-dependent transporter of glutathioneconjugates of electrophiles (GS-E) and DOX in | ||
erythrocytes. Can catalyze transport of glutathione conjugates and xenobiotics, and may | ||
contribute to the multidrug resistance phenomenon | ||
Transcription factor | ATF2 | Belongs to the bZIP family, ATF subfamily, binding the cAMP response element (CRE) |
and/or tumor suppressor | (consensus sequence: 5’GTGACGT(A/C)(A/G)-3') as a transcription activator | |
TP53 | Acts as a tumor suppressor in many tumor types, involved in cell cycle regulation | |
as a transcription activator that acts to negatively regulate cell division by controlling | ||
a set of genes required for this process | ||
The enzymes involved in | CAT | Belonging to the catalase family ,serves to protect cells from the toxic effects of |
drug activation or inactivation | hydrogen peroxide | |
metabolism abnormality | GSTP1 | Belongs to the GST superfamily. Pi family; Conjugation of reduced glutathione to |
a wide number of exogenous and endogenous hydrophobic electrophiles | ||
TOP2B | Control of topological states of DNA by ATP-dependent breakage, passage and | |
rejoining of double-stranded DNA | ||
DCK | Required for the phosphorylation of several deoxyribonucleosides and certain | |
nucleoside analogs widely employed as antiviral and chemotherapeutic agents | ||
Cell signaling alteration and | RAF1 | Belongs to the Ser/Thr family of protein kinases. RAF subfamily. Involved in |
cell cycle checkpoints alteration | the transduction of mitogenic signals from the cell membrane to the nucleus as a | |
part of the Ras-dependent signaling pathway from receptors to the nucleus | ||
SKP2 | Involved in regulation of G1/S transition as substrate recognition component of the | |
SCF (SKP1-CUL1-F- box protein) E3 ubiquitin ligase complex which mediates the | ||
ubiquitination and subsequent proteasomal degradation of target proteins involved in | ||
cell cycle progression, signal transduction and transcription | ||
Unclear mechanisms | B2M | Beta-2-microglobulin is the beta-chain of major histocompatibility complex class I |
molecules, Containing 1 immunoglobulin-like domain | ||
OCLN | May play a role in the formation and regulation of the tight junction (TJ) | |
paracellular permeability barrier | ||
SPF45 | Involved in nuclear mRNA splicing, via spliceosome |
GenBank No. | Gene symbol | Sense 5’-3’ | Antisense 5’-3’ | Position | Size(bp) | |
NT_016354 | ABCG2 | m | TGTCGCGTTGAGTCGTTA | AACGTCCCCGATACTTCG | -698 to -464 | 235 |
U | TGTGTTTTGTTGTGTTGAGTTGT | TCACTCTAATTCATTCCATTCAATC | -591 to -457 | 135 | ||
NT_005403 | ATF2 | m | GGGTCGGAATAACGAACG | ATCACCTCGAATACTCCTAACG | 230 to 375 | 146 |
U | GGAGGGGTTGGAATAATGAAT | CCCATTTCCCATCACCTCAA | 220 to 379 | 160 | ||
NT_010194 | B2M | m | ATTTGGTATTGCGTCGTTG | ACGAAACGAAACATCTCGAC | -128 to 23 | 151 |
U | TTTTTAATTTGGTATTGTGTTGTTG | AACTCACACTAAATAACCTCCAAAC | -134 to 83 | 217 | ||
NT_009237 | CAT | m | AGTAGCGGGTCGCGTAG | AACCACCCGAACCTATCG | 118 to 372 | 255 |
U | GGAAGGAGTAGTGGGTTGTGT | AACCACCCAAACCTATCACA | 112 to 372 | 261 | ||
NT_007933 | CFTR | m | AGAGGTCGCGATTGTCGTT | CGACTTTCTCCACCCACTACG | -316 to -114 | 203 |
U | TTAAAGAGAGGTTGTGATTGTTGTT | TCCTTCACTCCCTCACCA | -322 to -174 | 149 | ||
NT_006216 | DCK | m | TATACGCGCGGTTTCGT | CGCCGACGAATATCGAA | -168 to 27 | 195 |
U | TTTTTTGTTATATGTGTGGTTTTGT | TACCCCTCAACCCTCACC | -176 to -75 | 102 | ||
NT_078018 | OCLN | m | TGCGTTCGTTAGGTGAGC | CGAATCCCAACTCGAAAACG | 538 to 753 | 216 |
U | GTTAGGTGTGTTTGTTAGGTGAGT | CACACCTCTCTAATTCCCACA | 532 to 772 | 241 | ||
NT_022517 | RAF1 | m | TCGGTCGTTTTGGAAGTC | CCCTAAAACGCGAAACG | -72 to 180 | 252 |
U | GGTTTGGTTGTTTTGGAAGTT | CACCAAATATAACCACCTCCCACT | -2 to 183 | 185 | ||
NT_010859 | RALBP1 | m | GGGTAAGTCGTTCGTTTTCG | CCTCTCCGCTCAAACGACT | -495 to -215 | 281 |
U | GTTAGTATTATATTGGGGTAAGTTGTTTG | CCCTTCATCCCCAAACTCA | -510 to -371 | 140 | ||
NT_006576 | SKP2 | m | GTCGTAGCGTCGTTCGTT | CTACAACCCGCTCTACTTCG | -198 to 10 | 208 |
U | TTTTTTAGTTAGTTGTAGTGTTGTTTGTT | ACCCACTCTACTTCACAACCAC | -209 to 5 | 214 | ||
NT_077569 | SPF45 | m | AGTGTCGTTCGGTTTCGTT | CCTCGAAAACTCCGACTACG | -216 to -6 | 211 |
U | GTGGAGTGTTGTTTGGTTTTGT | AACTTACATCTAACACCTCCCAAA | -220 to -67 | 154 | ||
NT_022517 | TOP2B | m | TGGGTTTCGTCGTTTCGT | CCGCGCTAAACCCGAAC | -241 to -66 | 176 |
U | GGTTGTTGGGTTTTGTTGTTTT | TTCTCCTCAACCACCACACTAA | -254 to -60 | 195 | ||
NT_010718 | TP53 | m | CGGAGTCGAGAGTTCGTG | CCGAAAACACTTTACGTTCG | 157 to 279 | 123 |
U | GTTGAAAATATATGGAGTTGAGAGTTT | CTTTCCACAACAATAACACACTTC | 190 to 291 | 102 | ||
NT_033903 | GSTP1 | m | GCGATTTCGGGGATTTTA | ACGACGACGAAACTCCAA | -183 to 16 | 199 |
U | GTTGGGGATTTGGGAAAG | TATAAAAATAATCCCACCCCACT | -230 to -28 | 203 |
Gene | C/M | N/M | P |
GSTpi | 24/30 | 17/30 | 0.052 |
CFTR | 23/30 | 16/30 | 0.058 |
- Citation: Ding S, Gong BD, Yu J, Gu J, Zhang HY, Shang ZB, Fei Q, Wang P, Zhu JD. Methylation profile of the promoter CpG islands of 14 “drug-resistance” genes in hepatocellular carcinoma. World J Gastroenterol 2004; 10(23): 3433-3440
- URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3433.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3433